Article Details
Retrieved on: 2025-05-13 19:45:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article emphasizes that postmarket surveillance (PMS) in the medical device business is integral for regulatory compliance and business strategy. Regulations like EU 2017/745 and 2017/746 enhance safety and competitive advantage, aligned with MedTech Europe's initiatives.
Article found on: www.veeva.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here